Follicular lymphoma treatment has become diverse with the inclusion of surgical procedure, radiation therapy, and medication combination

 

Follicular Lymphoma Treatment

Follicular Lymphoma, otherwise known as follicular lymphoma is a type of cancer that occurs when the immune system attacks the tissues in the body. This type of cancer is generally seen in younger women and men and is almost unheard of in those who are over the age of 50. It is also not rare in those who have other forms of cancer such as breast cancer, rectal cancer, melanoma, and other types of skin cancer. Follicular Lymphoma has the same symptoms and causes as many other forms of cancer, although it is important to seek treatment if one notices these symptoms. The annual incidence of follicular lymphoma in the U.K. is 3 to 5 cases per 100,000 with the median age at diagnosis being 60-65 years.

In general, a doctor will perform a biopsy and examination on the tissue of those who have been diagnosed with this condition. During the exam, the doctor will look for tumors, masses, or any other abnormal growths. If cancer is found, then further treatment will be recommended. One of the most common follicular lymphoma treatments offered is radiation therapy. This type of treatment is used to treat those who have been diagnosed with non-Hodgkins lymphoma. Radiation therapy either employs x-rays or pellets that are made of irradiated material. The radiation damages the abnormal cells in the body and helps to normalize the flow of blood in the body.

Follicular lymphoma treatment can involve radiation therapy or surgical removal of the problem swollen cells. A combination of medications, medicines, and surgery is used to combat this condition. As with all cancer treatments, prevention is always better than cure. You should try to minimize your exposure to things that may trigger the growth and spread of the disease. A healthy diet, regular exercise, and relaxation techniques can also help to keep the disease at bay. Recently, in January 2021, the U.S. Food and Drug Administration (FDA) approved Yescarta for Relapsed or Refractory Follicular Lymphoma after two or more lines of systemic therapy.


Comments

Popular posts from this blog

Light Linear Alpha Olefins Are Produces through Oligomerization of Ethylene and by Fischer-Tropsch Synthesis

Cervical Cancer Diagnostic Tests have become highly sophisticated with accurate diagnosis for effective treatment

Beta Glucan-based products have been shown to be effective in lowering cholesterol and preventing heart disease